Jason R. Westin
The University of Sydney
2 papers in the Anchorcite directory, published between 2017 and 2018, cited 10,402 times in total.
ORCID profileResearch topics
- T-cell and B-cell Immunology · 2 papers
- CAR-T cell therapy research · 2 papers
- Lymphoma Diagnosis and Treatment · 2 papers
Frequent co-authors
- Sattva Swarup Neelapu · 1 paper
- Frederick Lundry Locke · 1 paper
- Nancy L. Bartlett · 1 paper
- Lazaros J. Lekakis · 1 paper
- David Bernard Miklos · 1 paper
- Caron Alyce Jacobson · 1 paper
- Ira Braunschweig · 1 paper
- Olalekan O. Oluwole · 1 paper
Papers
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaNew England Journal of Medicine · 2017 · 6,172 citations
BACKGROUND: In a phase 1 trial, axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, showed efficacy in patients with refractory large B-cell lymphoma after the failure of conventional therapy. METHODS: anti-CD19 CAR T cells per kilogram…
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell LymphomaNew England Journal of Medicine · 2018 · 4,230 citations
BACKGROUND: Patients with diffuse large B-cell lymphoma that is refractory to primary and second-line therapies or that has relapsed after stem-cell transplantation have a poor prognosis. The chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel targets and eliminates CD19-expressing B cells…
Metadata from OpenAlex (CC0).